In addition to identifying P. falciparum mutants with hrp2 deletion, these two multiplexed assays have been used for the investigation of the dynamics of antigen clearance, conducting malaria surveillance studies, anti-malarial drug clinical trials, and evaluating point-of-care tests [8, 14–16]. The gene discussed is HDGFL2; the disease is malaria.